GO
Loading...

Sanofi SA

More

  • Europe's main indices followed the overnight lead from Wall Street and Asia, although the third-quarter earnings reports out of Europe weren't quite as solid as those from the United States. Germany's DAX was up almost 1 percent in early trade, Britain's FTSE was up half a percent, and France's CAC 40 up a third of one percent. MSCI's broadest index of...

  • UPDATE 3-Sanofi board ousts CEO Viehbacher Wednesday, 29 Oct 2014 | 4:49 AM ET

    *Sanofi board says not changing company's strategy. PARIS, Oct 29- Sanofi's board ousted its chief executive of six years at a special meeting on Wednesday, two days after it emerged he had fallen out with the French drugmaker's chairman, wiping more billions off its market value. The board said Sanofi would continue the strategy of international expansion it had...

  • European shares rise ahead of Fed; Sanofi drops again Wednesday, 29 Oct 2014 | 4:12 AM ET

    PARIS, Oct 29- European shares rose early on Wednesday, tracking sharp gains on Wall Street ahead of the U.S. Shares in French pharma group Sanofi bucked the trend, dropping 5.3 percent and adding to the previous session's slump, after its board said on Wednesday it had decided to oust chief executive Chris Viehbacher. At 0807 GMT, the FTSEurofirst 300 index of top...

  • UPDATE 2-Sanofi board meets, report says CEO to be ousted Wednesday, 29 Oct 2014 | 3:52 AM ET

    *Sanofi shares fell over 10 pct on Tuesday. PARIS, Oct 29- Sanofi's board was on the verge of ousting its CEO at a special board meeting on Wednesday, according to Le Monde newspaper, two days after it emerged he had fallen out with the French drugmaker's chairman. Several sources close to Sanofi's board told Reuters of an increasingly frosty relationship between...

  • Weak oil price hits Total results Wednesday, 29 Oct 2014 | 3:40 AM ET

    Total warned that sliding oil prices had hit its third-quarter results and could weigh for the rest of 2014.

  • *Sanofi shares fell over 10 pct on Tuesday. PARIS, Oct 29- Sanofi will hold a special board meeting on Wednesday at 0700 GMT to examine the French drugmaker's management structure, a source close to Sanofi told Reuters amid uncertainty over the future of its chief executive. Several sources close to Sanofi's board told Reuters of an increasingly frosty...

  • Europe closes firmly higher; Sanofi plummets Tuesday, 28 Oct 2014 | 1:09 PM ET

    European stocks ended the day firmly in positive territory on Tuesday, as investors prepared for a key monetary policy decision from the U.S.

  • *Capital goods orders post largest fall in eight months. NEW YORK, Oct 28- U.S. stocks were set to rise at the open on Tuesday even as weaker-than-expected data cut gains in equity futures and as the Federal Reserve prepared to begin a two-day meeting on monetary policy. "Durable goods disappointed, and that points to cautious consumers and also that capital...

  • *Capital goods orders post largest fall in eight months. NEW YORK, Oct 28- U.S. stock index futures rose on Tuesday ahead of data on industrial production, home prices and consumer confidence and as the Federal Reserve prepared to begin a two-day meeting on monetary policy. *The economic schedule also includes S&P/Case-Shiller home prices for August at 9:00 a.m....

  • Robust earnings spur European stocks higher Tuesday, 28 Oct 2014 | 8:27 AM ET

    *Sanofi share drop means over $10 bln market value wipeout. EDINBURGH, Oct 28- European shares rose in early trade on Tuesday, reversing the previous session's dip as better-than-expected results from a number of blue-chips including pharma group Novartis and bank UBS helped lift sentiment. While French pharma Sanofi and UK- listed Standard Chartered Bank...

  • Early Movers: DD, PFE, AET, TWTR, MSG, WMT & more Tuesday, 28 Oct 2014 | 8:07 AM ET
    A trader works on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • US STOCKS-Futures rise ahead of data, Twitter tumbles Tuesday, 28 Oct 2014 | 7:48 AM ET

    NEW YORK, Oct 28- U.S. stock index futures rose on Tuesday ahead of data on industrial production, home prices and consumer confidence and as the Federal Reserve prepared to begin a two-day meeting on monetary policy. *A busy economic schedule includes September data on durable goods at 8:30 a.m., S&P/Case-Shiller home prices for August at 9:00 a.m. and at...

  • PARIS, Oct 28- French drugmaker Sanofi said sales growth at its leading business of diabetes treatments would stall next year due to tough competition on prices in the United States, sending its shares down more than 8 percent on Tuesday. The drop in Sanofi's shares was the steepest in five years and wiped 9.2 billion euros off the company's market value.

  • LONDON, Oct 28- U.S.-based Amgen, France's Sanofi and Ono Pharmaceutical of Japan have linked with three research institutes to study a super-family of proteins controlling everything from taste to the spread of cancer. Better information about their structure could help in the hunt for new drug candidates, the partners in the new GPCR Consortium believe.

  • Robust earnings help Europe stocks resume rally Tuesday, 28 Oct 2014 | 5:35 AM ET

    *FTSEurofirst 300 up 0.8 pct, Euro STOXX 50 up 0.9 pct. *Sanofi share drop represents $10 bln market value wipeout. PARIS, Oct 28- European shares rose in early trade on Tuesday, reversing the previous session's dip as better-than-expected results from a number of blue-chips including pharma group Novartis and bank UBS helped lift sentiment.

  • PARIS, Oct 28- French drugmaker Sanofi said its leading business of diabetes treatments would stall next year due to tough competition on prices, sending its shares down 7 percent on Tuesday. The drop in Sanofi's shares was the steepest in five years and wiped 7.8 billion euros off the company's market value. "The surprise in all of this to me is that this is a duopoly:...

  • Sanofi tanks 7.4% on diabetes business warning Tuesday, 28 Oct 2014 | 4:31 AM ET

    Shares of Sanofi tumbled around 7.4 percent early on Tuesday after the French drugmaker reported weaker-than-expected Q3 sales.

  • European shares rise early; Sanofi sinks Tuesday, 28 Oct 2014 | 4:08 AM ET

    PARIS, Oct 28- European shares rose in early trade on Tuesday, reversing the previous session's dip as better-than-expected results from a number of blue-chips including pharma group Novartis and bank UBS helped lift sentiment. At 0803 GMT, the FTSEurofirst 300 index of top European shares was up 0.6 percent at 1,313.05 points, with UBS up 1.9 percent and...

  • LONDON, Oct 27- Drugmakers sprinting to develop Ebola vaccines face a series of technical hurdles if they are to get millions of doses ready for use next year-- even assuming clinical trials are successful. The challenges include finding sufficient sterile capacity for filling and packaging finished vials, getting fast quality approvals from regulators, and...

  • BUSINESS-NEWS-SCHEDULE AT 0930 GMT /5.30 AM ET Monday, 27 Oct 2014 | 6:02 AM ET

    Monte dei Paschi drags Europe's banks lower post-stress test. LONDON- Italy's Monte dei Paschi slumps after having the biggest capital hole to fill in a health check of European banks that was generally seen as good news for the sector. BERLIN- German business sentiment darkens in October for a sixth month running, hitting its lowest level in almost two years and...